Literature DB >> 9278287

Design of a solubilization pathway for recombinant polypeptides in vivo through processing of a bi-protein with a viral protease.

J Pérez-Martin1, I Cases, V de Lorenzo.   

Abstract

An artificial maturation pathway for increasing the solubility in vivo of recombinant proteins overproduced in Escherichia coli is reported, which is based on the proteolytic processing of viral polyproteins. The gene product of interest is expressed as a fusion to a heterologous moiety (i.e. the maltose binding protein, MalE) in order to increase the overall solubility of the hybrid. The hinge region between the two fusion partners contains a cleavage site for the NIa protein, a very specific protease from the plum pox potyvirus, as well as an affinity tag. After production, the soluble hybrid is cleaved in vivo by the protease, that is encoded by a plasmid harboured by a specialized E.coli host. The released protein remains soluble and can be purified from cell extracts by means of an affinity tag (a poly-His group) that becomes present after the cleavage. The solubilization and purification of XylR, a xylene-responsive transcriptional factor of Pseudomonas, with this method are reported.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278287     DOI: 10.1093/protein/10.6.725

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  3 in total

1.  Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused.

Authors:  R B Kapust; D S Waugh
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Leucines 193 and 194 at the N-terminal domain of the XylS protein, the positive transcriptional regulator of the TOL meta-cleavage pathway, are involved in dimerization.

Authors:  Raquel Ruíz; Silvia Marqués; Juan L Ramos
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

3.  Specific and efficient cleavage of fusion proteins by recombinant plum pox virus NIa protease.

Authors:  Nuoyan Zheng; José de Jesús Pérez; Zhonghui Zhang; Elvira Domínguez; Juan Antonio Garcia; Qi Xie
Journal:  Protein Expr Purif       Date:  2007-10-22       Impact factor: 1.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.